Earlier investigations have also substantiated that QG can ameliorate the inflammatory condition in patients with CKD by decreasing the serum levels of IL-6, TNF-α, and hs-CRP, as well as mitigating renal fibrosis in patients concurrently experiencing chronic renal failure (123–126). This evidence concerns the gene IL6 and chronic kidney disease.